FIELD: pharmaceuticals.
SUBSTANCE: invention relates to the pharmaceutical industry and is a novel derivative of 4-hydroxybenzamide, namely 4-(4-acetoxybenzoylamino)butanoylglycine:
,
which has a pronounced cerebroprotective effect in cerebral ischemia.
EFFECT: invention provides an expansion of the arsenal of highly effective cerebroprotective agents.
1 cl, 2 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| 4-[(4-ACETOXYBENZOYL)AMINO]BUTYRATE OF LITHIUM, HAVING CEREBROPROTECTIVE ACTION | 2015 |
|
RU2617233C2 |
| BASIC MAGNESIUM SALT OF N-(4-ACETOXYBENZOYL)GLYCINE HAVING CEREBROPROTECTIVE ACTION | 2014 |
|
RU2570204C1 |
| N-(ACETYLSALICYLOYL)PYRAZOL WITH CEREBROPROTECTOR ACTION IN CASE OF CEREBRAL CIRCULATION INSUFFICIENCY | 2016 |
|
RU2632005C1 |
| POTASSIUM N-(4-ACETOXYBENZOYL)GLYCINATE POSSESSING CEREBROPROTECTIVE ACTIVITY | 2014 |
|
RU2556637C1 |
| DISODIUM SALT OF SALICYLURIC ACID, POSSESSING CEREBROPROTECTIVE ACTIVITY | 2014 |
|
RU2570644C1 |
| DERIVATIVES OF QUINAZOLINE-4 (3H)-ONE, WITH NEURO- AND CARDIOPROTECTIVE ACTIVITY | 2016 |
|
RU2622638C1 |
| DISODIUM SALT OF 3-HYDROXYHIPPURIC ACID, HAVING ANTIHYPOXIC AND CEREBROPROTECTIVE ACTION | 2014 |
|
RU2559875C1 |
| NEW WATER-SOLUBLE SALICYLAMIDE DERIVATIVE WITH NEUROPROTECTIVE ACTION IN CASE OF CEREBRAL CIRCULATION INSUFFICIENCY | 2017 |
|
RU2641102C1 |
| (2S,4S)-4-AMINO-N-(4-FLUOROPHENYL)PYROGLUTAMIC ACID EXHIBITING CEREBROPROTECTIVE, NOOTROPIC, AND ANTITHROMBOTIC ACTION | 2021 |
|
RU2769521C1 |
| AGENT POSSESSING NEUROPROTECTIVE ACTION IN ISCHEMIC CEREBRAL CIRCULATION DISORDER | 2015 |
|
RU2586301C1 |
